Multimodality Treatment of a Colorectal Cancer Stage IV Patient with FOLFOX-4, Bevacizumab, Rigvir Oncolytic Virus, and Surgery

Andra Tilgase (Corresponding Author), Evija Olmane, Jurijs Nazarovs, Linda Brokane, Romualds Erdmanis, Agnija Rasa, Peteris Alberts

Research output: Contribution to journalArticlepeer-review

8 Citations (Scopus)
8 Downloads (Pure)

Fingerprint

Dive into the research topics of 'Multimodality Treatment of a Colorectal Cancer Stage IV Patient with FOLFOX-4, Bevacizumab, Rigvir Oncolytic Virus, and Surgery'. Together they form a unique fingerprint.

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science